Abstract
A non-radioactive 2-deoxyglucose (2DG) analog has been developed here for hyperpolarized magnetic resonance investigations. The analog, [13C6,D8]2DG, showed 13% polarization in solution (27,000-fold signal enhancement at the C1 site), following a dissolution-DNP hyperpolarization process. The phosphorylation of this analog by yeast hexokinase (yHK) was monitored in real-time with a temporal resolution of 1 s. We show that yHK selectively utilizes the β anomer of the 2DG analog, thus revealing a surprising anomeric specificity of this reaction. Such anomeric selectivity was not observed for the reaction of yHK or bacterial glucokinase with a hyperpolarized glucose analog. yHK is highly similar to the human HK-2, which is overexpressed in malignancy. Thus, the current finding may shed a new light on a fundamental enzyme activity which is utilized in the most widespread molecular imaging technology for cancer detection – positron-emission tomography with 18F-2DG.
Similar content being viewed by others
Introduction
The hexokinase (HK) family of enzymes carry out the first step in glycolysis and therefore are of key importance in cellular metabolism1. HKs play an important role in malignancy: one of the earliest observations in malignant transformation is an increased glycolytic flux2, which is largely attributed to changes in the activity of HKs. For example, in rapidly growing tumor cells, HK expression is markedly elevated and most of the enzyme is localized to the mitochondrial membrane3,4, which provides HK with increased ATP availability resulting in increased activity5.
HK isoenzymes vary in function and in organ expression. In health, HK-4 (glucokinase, GK) is important in glucose sensing in the pancreas and in the liver6 while HK-1 and HK-2 mainly function in other tissues such as muscle and brain. Increased or decreased HK expression has been found to correlate with the clinical outcome in a number of disease states7,8,9,10,11,12,13,14,15,16,17,18,19,20. Elevated HK-2 expression is correlated with higher histological grade in hepatocellular carcinoma (HCC)7 as during the process of HCC tumorigenesis, normal GK expression is silenced, and HK-1 and HK-2 are overexpressed8,9. Since the affinity of HK-1 and HK-2 for glucose is higher than that of GK, their expression results in increased glucose utilization which supports HCC tumorigenesis. HK-2 expression was shown to be correlated with the survival of patients with HCC, gastric and colorectal cancer, and WHO grade IV glioblastoma10,11,12,13,20. Aggressive types of cancer including pancreatic ductal adenocarcinoma14, renal cell carcinoma15, medulloblastoma16, and mouse models of lung and breast cancer17 are characterized by high levels of HK-2. Other non-malignant diseases with increased HK-2 expression in the liver include fatty liver disease18, and hepatitis C virus infection19.
[18F]Fluoro-2-deoxy-D-glucose (FDG) is the most widely used tracer in positron emission tomography (PET) for detecting, staging, and monitoring of various malignancies21. It was previously suggested that the increased HK-2 activity forms the basis for the utility of FDG-PET imaging of malignant tumors5. Nuclear magnetic resonance (NMR) has been used for the study of glucose and 2-deoxyglucose (2DG) metabolism22,23,24,25. In 13C-NMR, as opposed to PET, the chemical evolution of 2DG to 2DG-6-phosphate (2DG6P) can be discerned. This property could be useful for differentiating the effects of glucose transporters expression from those of HK expression in vivo. For the above reasons, glucose and 2DG imaging has been a desired target in magnetic resonance imaging, which does not involve ionizing radiation. MR investigations of glucose and 2DG have been carried out using the gluco-CEST approach22,26,27, thermal equilibrium 13C-NMR with carbon-13 labeled substrates28, and deuterium metabolic imaging (DMI)29.
The introduction of the dissolution-dynamic nuclear polarization (dDNP) technique has allowed more than a 10,000-fold increase in the observed 13C-NMR signal in solution30, and thus enabled research of fast biochemical conversion processes on time scales of seconds, not possible with thermal equilibrium 13C-NMR. dDNP was extensively used to study in vivo enzymatic conversion processes in animal models of health and disease31 and recently in humans32,33,34,35,36,37. dDNP-NMR was also used in in vitro studies such as kinetics of enzymatic reactions38,39,40,41, reactive oxygen species production42, protein-substrate interactions43, protein folding44, and diffusion in solution45. With regards to glucose metabolism, hyperpolarized [13C6,D7]glucose was used to demonstrate HK-mediated conversion to G6P, and G6P inhibition of this reaction38. Hyperpolarized [13C6,D7]glucose was also used to study metabolism in cell cultures46 and its distribution in the body was demonstrated in real-time by hyperpolarized MRI47. Real-time monitoring of hyperpolarized [13C6,D7]glucose metabolism in vivo, in a lymphoma model in mice, showed lactate production in the tumor, but not in surrounding tissues48, and an injection of hyperpolarized [13C6,D7]glucose to the normal mouse brain was followed by observation of lactate and pyruvate by 13C MRS in sub-second temporal resolution49. These latter studies demonstrate the ability to monitor the metabolic conversions of [13C6,D7]glucose in a hyperpolarized state despite the fast metabolism and despite the relatively shorter life time of the hyperpolarized state47 compared to other dDNP probes. However, the fast metabolism and conversion to the freely diffusing [13C]CO2 also hinders the ability to image this powerful agent with hyperpolarized MRI. For this reason, the PET examination utilizes 2DG – a glucose derivative that undergoes phosphorylation only, whereas this phosphorylated form remains intracellular.
To develop an MRI parallel of the FDG-PET examination we have previously designed a 2DG analog with similar isotopic-labeling strategy as that used for hyperpolarized glucose studies, i.e. a uniform 13C label and deuteration of all SP3 carbons ([13C6,D8]2DG)50. Here we have studied the HK activity on this analog in a hyperpolarized state. A fast acting, readily available HK from the yeast Saccharomyces cerevisiae (yHK) was used here as a model for mammalian HKs due to its high similarity51,52,53 (further information is provided in the Discussion and Supplementary Information S3). As a control, we used the activity of this enzyme on hyperpolarized [13C6,D7]glucose. Studies with bacterial GK (bGK) which bears no similarity to the human enzymes and which is not expected to react with 2DG54,55 were also performed and served to highlight traits in the spectral consequences of enzymatic activity on [13C6,D8]2DG and [13C6,D7]glucose.
Using a comprehensive kinetic analysis and decomposition of the complex and overlapping [13C6,D8]2DG and [13C6,D8]2DG6P signals we found a differential activity of the yHK on the α and β anomers of [13C6,D8]2DG as opposed to a non-differential activity on [13C6,D7]glucose anomers. The high temporal resolution (seconds) enabled by the hyperpolarized MR technology was key in the ability to perform this study and reach this conclusion. The importance of this finding for understanding HK activities in cancer warrants further investigation and is important for the development of such a potential tracer for hyperpolarized MRI.
Results
[13C6,D8]2DG is visible in a hyperpolarized state
Following 1.8 to 2.3 h of polarization in the dDNP polarizer (formulation and polarization described in the Methods), [13C6,D8]2DG was observed in a hyperpolarized state in solution as described in Table 1. Typical 13C-NMR spectra of [13C6,D8]2DG in a hyperpolarized state and at thermal equilibrium are shown in Fig. 1.
The phosphorylation of [13C6,D8]2DG is detectable in real-time by hyperpolarized NMR in the reaction with yHK
Next, we investigated the ability to follow the phosphorylation of [13C6,D8]2DG with yHK and with bGK. To this end, hyperpolarized [13C6,D8]2DG was directly injected to an NMR tube containing the enzymatic reaction buffer solution (Methods) and the yHK or bGK enzyme. In the reactions with yHK, hyperpolarized [13C6,D8]2DG6P was observed immediately – already in the first spectrum acquired after the arrival of the hyperpolarized medium into the NMR tube (within 1 s), as can be seen in Fig. 2A,B (middle panel, signal at 66.18 ppm), and 2C. However, the conversion of [13C6,D8]2DG to [13C6,D8]2DG6P was not observed in the reaction with bGK (Fig. 2D, middle panel). The low intensity multiplet observed at a chemical shift close to that of the C6 position of [13C6,D8]2DG6P is likely due to the heptamer form of this compound, as previously reported for glucose56,57. These signals also appear in the experiment carried out without an enzyme (Fig. 2F, middle panel). As the lack of reaction of bGK on 2DG observed here was in agreement with prior publications54,55, this experiment was carried out only twice.
Interestingly, in the reaction with yHK, the signals of the β anomer appeared to decay faster compared to the α anomer, with an apparent T1 that is about 31% shorter for the C1 position and 29% for the C2 position (Table 2). No significant differences were observed in the experiments carried out without an enzyme (Supplementary Information S1) or with bGK (Table 2).
Quick [13C6,D7]glucose phosphorylation by both yHK and bGK is detectable in real-time in a hyperpolarized state
As a control for the experiments with [13C6,D8]2DG, we have tested the same reactions with hyperpolarized [13C6,D7]glucose. In these experiments, in the presence of both yHK (Fig. 3B) or bGK (Fig. 3D) the C6 signal of [13C6,D7]G6P builds up immediately and then decays, indicating the quick production of hyperpolarized [13C6,D7]G6P. As opposed to the reactions with [13C6,D8]2DG, [13C6,D7]glucose reacted also with bGK. As expected, in the experiment without an enzyme, the signal of [13C6,D7]G6P was not observed, although some experiments showed a faint signal at a nearby chemical shift – attributed to the heptamer form of [13C6, D7]glucose56,57. As opposed to the reaction of [13C6,D8]2DG with yHK, in both reactions with [13C6,D7]glucose the decay rate of the C1α and C1β signals appeared similar and these signals were characterized by similar apparent T1s (Table 2).
Further analyses of the reactions with [13C6,D8]2DG and [13C6,D7]glucose
Table 2 shows the apparent T1 relaxation times that were determined for the signals of [13C6,D8]2DG and [13C6,D7]glucose in the presence of yHK, for those signals that could be spectrally resolved. In the reactions of [13C6,D8]2DG, the apparent T1s of the C1 and C2 carbons of the two anomers of the combined [13C6,D8]2DG and [13C6,D8]2DG6P signals were found to be different with the T1 of the β anomer signals being about 30% shorter than that of the α anomer in both positions. This effect was not observed for the reaction of [13C6,D8]2DG with bGK (where no phosphorylation occurred) and for the reactions of [13C6,D7]glucose with yHK or with bGK. We note that the T1 of the C1 position of both anomers in both [13C6,D7]glucose and [13C6,D8]2DG is longer at 40 °C compared to room temperature, with this effect being more pronounced for [13C6,D8]2DG and apparent also for its C2 position (Supplementary Information S1).
The C6 signal in these experiments was useful for characterizing the reaction rate constants as the substrate and the product signals were well resolved in this site. Therefore, the time course of the C6 signals of the substrate and product were fitted to a kinetic model which considers the metabolic reaction as a first-order reaction39. The metabolic rate constants that were obtained are provided in Supplementary Table S2.
The reaction of [13C6,D8]2DG with yHK reveals a decrease in the β to α anomeric ratio
Figure 4 shows the change in the ratio of anomers over the course of the reactions of [13C6,D8]2DG and [13C6,D7]glucose with yHK and bGK. In addition to the fast decay of C1β of [13C6,D8]2DG, this experiment also revealed different reaction kinetics for the two anomers present in the reaction medium. In Fig. 4A, it can be seen that the β/α ratio of the C1 position is decreasing during the first 20 s and then increasing. We wished to determine if this behavior is unique to [13C6,D8]2DG by inspecting the same parameter in the experiments with [13C6,D7]glucose. As shown in Fig. 4B, the reaction of [13C6,D7]glucose with yHK did not show this behavior, rather - a slightly increasing β/α C1 ratio can be seen during the same reaction time.
To further investigate this behavior, we analyzed the reactions of both substrates with bGK in the same way. Figure 4C,D show this analysis for [13C6,D8]2DG and [13C6,D7]glucose, resulting in a relatively constant ratio throughout the observation window. The experiments without enzymes (Fig. 4E,F for [13C6,D8]2DG and [13C6,D7]glucose, respectively) also showed a C1 β/α ratio that is relatively constant, all in contrast to the reaction of [13C6,D8]2DG with yHK.
Quantification of the anomer specific substrate and product time courses in the reaction of [13C6,D8]2DG with yHK
To further investigate the underlying reason for the temporal changes in the anomeric ratio in the reaction of [13C6,D8]2DG with yHK we aimed at quantifying the composition of the two anomers in terms of substrate and product during the course of the reaction. Due to the significant overlap between the signals of [13C6,D8]2DG and [13C6,D8]2DG6P in each of the anomer signals, a spectral deconvolution analysis was applied. The C1 signals were the only signals where this information could be obtained because: 1) the C3-C5 signals of [13C6,D8]2DG and [13C6,D8]2DG6P overlapped, 2) in the C3-C6 signals of both compounds, anomer differentiation was not possible, and 3) as regards to the C2 site signals, although this site showed resolved anomer signals, these signals were broader than the signals of the other sites as a result of more extensive splitting due to coupling with two attached deuterons. Consequently, deconvolution of the anomeric signals to their [13C6,D8]2DG and [13C6,D8]2DG6P components was not possible for this site (Supplementary Information S4). An example of the deconvolution operation on the C1 signals for one spectrum is shown in Fig. 5.
The ability to deconvolve the complex signals to their respective [13C6,D8]2DG6P and [13C6,D8]2DG components allowed monitoring of the temporal evolution of each of these components in the course of the reaction. The deconvolution procedure relied on the ability to resolve (at least partially) a few unique signals for each of the components (assignment shown in Supplementary Information S5). A typical example of such unique signals is shown in Fig. 6. It can be observed that the [13C6,D8]2DG6P component is increasing with time in both the C1α and C1β signals (Fig. 6A, blue lines). It can also be seen that the [13C6,D8]2DG component is decreasing in the C1β signal in comparison to the C1α signal (Fig. 6A, red lines).
The overall proportion of the [13C6,D8]2DG6P component and the [13C6,D8]2DG component, as derived from this deconvolution procedure applied on the C1 signals, was in agreement with an analysis of these components in the C6 signal, in which the signals of the substrate and the product are resolved, but the anomers are not (Fig. 6B). This result served as a validation for the deconvolution results. The normalized root mean square deviation (NRMSD) for the ratio of product signal to total signal between the C1 and C6 based determinations was found to be 16 ± 9%, n = 5).
Anomeric selectivity of yHK for the β anomer of [13C6,D8]2DG
During the reaction with yHK, the β/α ratio of [13C6,D8]2DG (the substrate) appeared decreasing with time, and within no more than 20 s this ratio reached zero as no more β signal was observed (Fig. 6C, plus signs). This finding suggested a selective consumption of the β anomer. On the other hand, the β/α ratio of the product (Fig. 6C, diamonds) appeared increasing throughout the time that the β anomer of the substrate was present, then slightly decreased towards a steady level. Because the anomerization rate of G6P is known to be about 500-fold faster than that of glucose and assuming that the same is true for DG and DG6P, it appears reasonable that this result reflects the fast anomerization rate of the product, i.e. [13C6,D8]2DG6P. Since the mutarotation rate of 2-deoxy-D-glucose is more than 10-fold higher than that of D-glucose58, these results and the difference from the reaction with [13C6,D7]glucose, cannot be explained by differences in the mutarotation rate of the substrate. Therefore, the results suggest that [13C6,D8]2DG6P is formed in the β anomeric form and then quickly reaches anomeric equilibrium. Thus, in the first part of the reaction, before the consumption of the β anomer of the substrate is completed, we observe two competing processes as regards to the β anomer of the product: on one hand - the production of the β anomer leads to an increase in its signal, and on the other, the continuous rapid establishment of anomeric equilibrium leads to a decrease in this signal. Once the consumption of the β anomer of the substrate is completed, we observe a decrease in the content of the β anomer of the product and arrival to an equilibrium represented by the steady level of this ratio (β/α = 0.92 ± 0.10, n = 5).
Discussion
2DG in its radioactive form – FDG, is the most abundant tracer in clinical PET examinations. Here, we were interested in researching the ability to monitor the activity of an analog of this tracer in a hyperpolarized state by magnetic resonance. To this end, we have used a 2DG analog uniformly labeled with 13C and deuterium as previously done for observing glucose in a hyperpolarized state38,46,47,48,49,50. We show here the 13C NMR signals of this 2DG analog ([13C6D8]2DG) in a hyperpolarized state with 13% polarization level for the C1 site at about 10–11 mM concentration.
After validating that indeed this analog can be detected on single 13C NMR acquisitions at this concentration, we utilized it for direct and real-time monitoring of the phosphorylation reactions. In the reaction with yHK, [13C6,D8]2DG was phosphorylated rapidly, but the signal of C1β appeared to decay faster compared to the C1α signal. This effect was also manifested as a decrease in the β to α ratio of the overlapping C1 signal of [13C6,D8]2DG and [13C6,D8]2DG6P during the reaction time. To investigate this effect further, we deconvolved the signal and found that the β/α ratio of the substrate, in particular, decreased until the β anomer was completely consumed. This result suggested that yHK has an anomeric selectivity for the β anomer of [13C6,D8]2DG. The presence of the α anomer of the product is likely explained by a fast anomerization of the newly formed [13C6,D8]2DG6P. This assumption is supported by prior investigations that found that the anomerization rate of glucose-6-phosphate is about 500-fold faster than that of glucose59. To the best of our knowledge, the anomerization rate of 2DG6P has not been reported. We note that the lack of anomeric selectivity and the slightly increasing C1 β/α ratio seen in the reaction of yHK with hyperpolarized [13C6,D7]glucose are in agreement with the slight anomeric preference of this reaction towards the β anomer observed by Okuda et al. in 1984 for hexokinase A in yeast60, while Miclet et al.38 reported comparable kinetics for both anomers of [13C6,D7]glucose.
The yHK used in this study, from the yeast Saccharomyces cerevisiae, previously showed similarity to mammalian HKs in terms of nucleotide and amino acid sequence51, with 35% amino acid homology compared to the C-terminus end of mammalian hexokinases53. Specifically, it was shown that the substrate-binding regions for glucose are conserved between the yHK and the HK found in rapidly growing tumor cells52. When comparing the amino acid sequence by global pairwise alignment, we found 29.4% identity and 48.1% similarity between yHK and human HK-2 (Supplementary Information S3). Therefore, this work may represent a preliminary step for studying HK properties of cancerous tissues.
If the anomeric selectivity revealed here for yHK is also present in human HK, the findings of the current study may shed a new light on this important reaction. Various glucose transporters have varying anomeric preferences. For example, intestinal cells61 as well as Ehrlich ascites tumors cells62 showed preference for the β anomer. In human erythrocytes, initial reports indicated that cross-membrane glucose transport has a preference for the β anomer63, but later studies showed no difference between the two anomers64,65. In the pancreas, β cells show preferential uptake of β-D-glucose as compared to α-D-glucose and increased insulin release in the presence of α-D-glucose as compared to β-D-glucose66. However, this anomeric specificity is perturbed in animal models of diabetes67,68. It was also previously shown that the anomeric preference of glucose metabolic enzymes that is observed in normal mammalian cells is absent in tumor cells69. If these perturbations are also manifested using [13C6,D8]2DG, it is possible that by imaging the anomeric preference of tissues, cancerous lesions can be detected by such loss of anomeric preference and treatments for diabetes may be monitored as well.
So far, due to the relatively fast anomerization times in physiologic temperature, the investigation of anomeric preference in live tissues was limited. Owing to the high temporal resolution enabled by the dDNP technology, and its translational nature, it may now be possible to re-visit the anomeric preference of enzymatic processes in live tissues and eventually in the whole animal, with the long-term goal of utilizing these differences for differential diagnoses and treatment monitoring.
It is interesting to suggest implications of the anomeric selectivity found here for FDG-PET imaging, which is the most widely used molecular imaging technology for cancer detection and staging. Interestingly, FDG is commonly synthesized from a starting material that is in the β anomeric form70. However, it is likely that anomeric equilibrium is established during the synthesis (in the acidification stages70) and later on during the time allowed for washout in PET imaging (from injection to imaging, ~1 h). Therefore, it is not clear that standard PET findings should be interpreted any different due to the current findings. However, it may provide useful information for quantitative first-pass PET imaging. In this type of imaging, which is mostly used for research purposes and where the relevant time scales are much faster – on the order of tens of seconds, it is very likely that HK activity is predominantly recorded and it could be useful to consider that the relevant substrate concentration may be only that of the β anomer.
Since its introduction, the only tracer used clinically with hyperpolarized MR was [1-13C]pyruvate32,33,34. We believe that the current study may set the foundations for further research regarding imaging possibilities with [13C6,D8]2DG. [13C6,D8]2DG shows beneficial T1 profile in the physiological temperature range compared to room temperature with a relative improvement of about 1.6-fold in T1 (C1 carbon, Supplementary Information S1). Because the short T1 relaxation time limits the clinical utility of hyperpolarized 13C labeled tracers, this is an important advantage. The current study may also imply that the T1 of [13C6,D8]2DG may be further prolonged at higher temperatures and this could enable better preservation of the polarization prior to injection of the hyperpolarized agent to the subject. This aspect will be further investigated in the future.
In the following we will review the pros and cons of a hypothetical MRI scanning with hyperpolarized [13C6,D8]2DG compared to other imaging techniques using a 2DG or glucose tracers.
An important advantage for a dDNP-MRI method over FDG-PET imaging is the ability to detect enzymatic conversion of the imaging probes, i.e. that the substrate and product signals can be resolved, and that this detection occurs within seconds. 2DG does not go through further metabolic steps in the glycolysis pathway after its phosphorylation, and is mostly found in its phosphorylated form71, 2DG6P, which is intracellular. PET imaging relies on this principle and therefore employs a delay between contrast injection to imaging to allow extracellular FDG to wash out prior to image acquisition. However, with hyperpolarized 2DG there may be no need to wait for the washout of the injected substrate, as the detection of phosphorylated product is possible and occurs in real-time. This short time scale may allow better quantification of enzymatic rates which may provide a new window for tissue characterization and differentiation from normal background tissue activity. These factors may allow imaging of tissues for which the background uptake of FDG is high and limits diagnostic imaging such as the brain and the heart.
Another diagnosis that may benefit from shortening the time from tracer administration to imaging is the characterization of hepatocellular carcinoma (HCC) lesions. The intensity of HCC relative to the normal liver (as in other tissues) in FDG-PET depends on the ratio between the phosphorylation of FDG and the dephosphorylation of FDG-6P by glucose-6-phosphatase72. Because glucose-6-phosphatase expression is variable in HCC, FDG-PET imaging only has around 50% sensitivity in HCC detection73. It appears possible that shortening the time between the injection of tracer and image acquisition will open new imaging capabilities for HCC as it may enable monitoring of the phosphorylation reaction before the phosphatase reaction takes place.
The major advantage of hyperpolarized MRI as compared to PET imaging is the use of non-ionizing radiation. However, the con of hyperpolarized MRI in this regard is the use of non-trace amounts of the imaging probe. Hyperpolarized [13C6,D7]glucose was visible in 0.12 g/kg in rats47, and it is likely that [13C6,D8]2DG will be visible in a similar dose. It is important to note that 2DG was found to be non-toxic in doses up to 0.5 g/kg when administered intravenously to rats74. Therefore, it appears likely that [13C6,D8]2DG can be observed in a hyperpolarized state in vivo without toxic effects.
Competing MR technologies are gluco-CEST22,26,27 and deuterium metabolic imaging (DMI)29. The advantage of the gluco-CEST technology is the use of the 1H channel that is available on all MRI scanners and the ability to use non-labeled imaging probes (2DG or glucose)22,26,27. However, the SNR on gluco-CEST imaging is low. The overall signal change from baseline on CEST imaging was not more than 2-fold22, which is far less than that of hyperpolarized MRI as in the latter the background signal is very low. In comparison, the SNR of hyperpolarized [13C6,D7]glucose MRI was 100,00047. The advantages of the DMI technology include the ability to use oral administration of the imaging probe and resolve metabolism to lactate, and an improved SNR due to the low background signal29. However, the acquisition time of the images was long (ca. 30 min)29. The con of both gluco-CEST and DMI is the lack of ability to discern the phosphorylated product from the substrate. However, a recent CEST study did show that the signal change observed was higher on DG injection than on glucose injection, suggesting accumulation of DG6P in the brain22. Considering these pros and cons of each 2DG/glucose based imaging technology and the central role these imaging probes play in biology and pathology, it is possible that a synergistic combination between them can yield better results than each technique alone.
In summary, we show the potential of [13C6,D8]2DG to serve as an imaging probe for hyperpolarized MRI and find that HK has a unique selectivity for the β anomer of this potential molecular imaging probe, which may provide a new contrast mechanism on MR.
Methods
Chemicals
The OXO63 radical (GE Healthcare, UK) was obtained from Oxford Instruments Molecular Biotools (Oxford, UK). [13C6,D7]glucose was obtained from Cambridge Isotope Laboratories (Tewksbury, MA, USA), [13C6,D8]2DG was obtained from 13C Molecular (Fayetteville, NC, USA). Glucokinase from Bacillus stearothermophilus, and hexokinase from Saccharomyces cerevisiae and all other chemicals used herein were purchased from Sigma-Aldrich (Rehovot, Israel).
DNP spin polarization and dissolution
Spin polarization and fast dissolution were carried out in a dDNP spin polarization device (HyperSense, Oxford Instruments Molecular Biotools, Oxford, UK) operating at 3.35 T. For polarization, microwave frequency of 94 GHz at 100 mW was applied for 1.4–2.3 h at 1.39–1.45 K. The formulations consisted of 14 mM OXO63 radical and 0.7 or 1.3 mM Gd3+, with a 80/100 w/w ratio of 2DG and purified H2O, respectively. Prior to insertion to the spin polarizer, the samples were kept at room temperature for ca. 2 h to allow for anomeric equilibration of [13C6,D7]glucose and [13C6,D8]2DG. Dissolution was performed with 4 mL of 100 mM TRIS HCl buffer at a pH of 7.6.
NMR spectroscopy
13C NMR spectroscopy was performed in a 5.8 T non-shielded high resolution NMR spectrometer (RS2D, Mundolshein, France) located about 2.2 meters away from the spin-polarization magnet (center-to-center), using a 10 mm broad-band NMR probe. All spectra were acquired with a 10° nutation angle, a repetition time of 1 s, and 19 kHz spectral width.
Enhancement factor and polarization percent calculation
The enhancement factor was calculated by comparing the maximal integrated signal intensity obtained under hyperpolarized conditions to the integrated signal intensity of the same sample at thermal equilibrium, acquired with the same nutation angle under fully relaxed conditions. In order to compare the integrated intensities from the thermal and hyperpolarized acquisitions, the same acquisition (spectral width, number of points, receiver gain), and processing (exponential line broadening, zero-filling) parameters were used. The thermal equilibrium spectrum was corrected for number of scans. Percent polarization in solution was calculated by multiplying the enhancement factor by the theoretical percent polarization of 13C at thermal equilibrium in the same magnetic field (5.8 T).
Experimental design and enzymatic assays
In experiments using yHK, ATP disodium was dissolved in 1 ml of TRIS HCl medium with MgCl2. The pH was then corrected with 10% NaOH solution to 7.675 and ~130 units of hexokinase were added and gently mixed until a clear solution was obtained. This solution was placed in an NMR tube which was placed within the spectrometer’s probe. In experiments with bGK, ATP disodium was dissolved in 2 ml of TRIS HCl medium with MgCl2, the pH was corrected and the solution was added into 100 units of bGK. Half of this solution (50 units) was used per experiment. The final reaction concentrations, after combining these enzyme solutions with the dissolution medium, were 20.0 ± 0.5 mM ATP, 10 mM MgCl2, and 10.9 ± 0.8 mM of hyperpolarized substrate. The hyperpolarized solution containing [13C6,D7]glucose or [13C6,D8]2DG was injected via a Teflon line from the spin-polarizer directly into the NMR tube containing the enzymatic mixture (yHK or bGK) within 3 s of Helium (g) chase. For the experiments shown in Fig. 4D,F, mixing was confirmed by visual inspection for uniformly distributed greenish color indicating adequate mixing of the hyperpolarized substrate before starting data acquisition. For the other experiments, the dissolution of the hyperpolarized substrate was done while the NMR tube was already inside the probe of the NMR spectrometer. The yHK reactions were performed at room temperature (ca. 21 °C). The experiments with bGK were performed at 40 °C, achieved by heating both the NMR tube and the dissolution medium transfer line. The temperature of the reactions with bGK was confirmed in real-time by a temperature probe inside the NMR tube (Osensa, Burnaby, BC, Canada).
Spectral processing and data analysis
Spectral processing was performed using MNova (Mestrelab Research, Santiago de Compostela, Spain). Integrated intensities were calculated either with MNova or with DMFIT76. Signal deconvolution analysis was carried out with DMFIT76.
T1 calculation
T1 determination in hyperpolarized decays measured without enzymatic reactions, and apparent T1 determination of hyperpolarized decays measured during enzymatic reactions - not taking into account reaction kinetics, were performed by curve fitting of the signal decay to the following equation \(M(t)={M}_{0}\cdot {e}^{(\frac{-t}{{T}_{1}})}\cdot \,\cos \,{\theta }^{(\frac{t}{TR})}\) in which TR, the repetition time, and θ, the nutation angle of excitation, are known. Curve fitting analysis was performed using Matlab (Mathworks, Natick, MA, USA). In experiments in which enzymatic conversion occurred and for sites in which this reaction could be discerned (the C6 position), the T1s were determined using a previously published model39, which enables the simultaneous determination of both the reaction rate constants and the T1s of the substrate and product.
Data availability
The data that support the findings of this study are available from the corresponding author on request.
References
Wilson, J. E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 206, 2049–2057 (2003).
Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635–649, https://doi.org/10.1038/nrc.2016.77 (2016).
Bustamante, E., Morris, H. P. & Pedersen, P. L. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J. Biol. Chem. 256, 8699–8704 (1981).
Parry, D. M. & Pedersen, P. L. Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J. Biol. Chem. 258, 10904–10912 (1983).
Mathupala, S. P., Ko, Y. H. & Pedersen, P. L. Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin. Cancer. Biol. 19, 17–24, https://doi.org/10.1016/j.semcancer.2008.11.006 (2009).
Bouche, C., Serdy, S., Kahn, C. R. & Goldfine, A. B. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr. Rev. 25, 807–830, https://doi.org/10.1210/er.2003-0026 (2004).
Guzman, G. et al. Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma. Dig. Dis. Sci. 60, 420–426, https://doi.org/10.1007/s10620-014-3364-3 (2015).
Rempel, A., Bannasch, P. & Mayer, D. Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim. Biophys. Acta 1219, 660–668, https://doi.org/10.1016/0167-4781(94)90225-9 (1994).
Mathupala, S. P., Rempel, A. & Pedersen, P. L. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J. Bioenerg. Biomembr. 29, 339–343 (1997).
Kwee, S. A., Hernandez, B., Chan, O. & Wong, L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: Association with survival. PLOS One 7, e46591, https://doi.org/10.1371/journal.pone.0046591 (2012).
Gong, L. et al. Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II. Med. Oncol. 29, 909–914, https://doi.org/10.1007/s12032-011-9841-z (2012).
Wu, J., Hu, L., Hu, F., Zou, L. & He, T. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis. Oncotarget 8, 32332–32344, https://doi.org/10.18632/oncotarget.15974 (2017).
Wolf, A. et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 208, 313–326, https://doi.org/10.1084/jem.20101470 (2011).
Anderson, M., Marayati, R., Moffitt, R. & Yeh, J. J. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer. Oncotarget 8, 56081–56094, https://doi.org/10.18632/oncotarget.9760 (2017).
Yoshino, H. et al. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci. 104, 1567–1574, https://doi.org/10.1111/cas.12280 (2013).
Gershon, T. R. et al. Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma. Cancer Metab. 1, 2, https://doi.org/10.1186/2049-3002-1-2 (2013).
Patra, K. C. et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 24, 213–228, https://doi.org/10.1016/j.ccr.2013.06.014 (2013).
Panasyuk, G. et al. PPARγ contributes to PKM2 and HK2 expression in fatty liver. Nat. Commun. 3, 672, https://doi.org/10.1038/ncomms1667 (2012).
Ramiere, C. et al. Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A. J. Virol. 88, 3246–3254, https://doi.org/10.1128/jvi.02862-13 (2014).
Ho, N. & Coomber, B. L. Hexokinase II expression is correlated with colorectal cancer prognosis. Cancer Treat. Commun. 6, 11–16, https://doi.org/10.1016/j.ctrc.2016.02.008 (2016).
Belhocine, T. et al. 18FDG PET in oncology: the best and the worst (Review). Int. J. Oncol. 28, 1249–1261 (2006).
Nasrallah, F. A., Pages, G., Kuchel, P. W., Golay, X. & Chuang, K. H. Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J. Cereb. Blood Flow Metab. 33, 1270–1278, https://doi.org/10.1038/jcbfm.2013.79 (2013).
Ugurbil, K., Brown, T. R., den Hollander, J. A., Glynn, P. & Shulman, R. G. High-resolution 13C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli. Proc. Natl. Acad. Sci. USA 75, 3742–3746 (1978).
Garcia-Espinosa, Ma. A. et al. Cerebral glucose metabolism and the glutamine cycle as detected by in vivo and in vitro 13C NMR spectroscopy. Neurochem. Int. 45, 297–303, https://doi.org/10.1016/j.neuint.2003.08.014 (2004).
Navon, G., Lyon, R. C., Kaplan, O. & Cohen, J. S. Monitoring the transport and phosphorylation of 2-deoxy-D-glucose in tumor cells in vivo and in vitro by 13C nuclear magnetic resonance spectroscopy. FEBS Lett. 247, 86–90 (1989).
Walker-Samuel, S. et al. In vivo imaging of glucose uptake and metabolism in tumors. Nat. Med. 19, 1067–1072, https://doi.org/10.1038/nm.3252 (2013).
Wang, J. et al. Magnetic resonance imaging of glucose uptake and metabolism in patients with head and neck cancer. Sci. Rep. 6, 30618, https://doi.org/10.1038/srep30618 (2016).
Gruetter, R. et al. Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc. Natl. Acad. Sci. USA 89, 1109–1112 (1992).
De Feyter, H. M. et al. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism. in vivo. Sci. Adv. 4, eaat7314, https://doi.org/10.1126/sciadv.aat7314 (2018).
Ardenkjaer-Larsen, J. H. et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA 100, 10158–10163, https://doi.org/10.1073/pnas.1733835100 (2003).
Kurhanewicz, J. et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: Prospects for translation to clinical research. Neoplasia 13, 81–97, https://doi.org/10.1593/neo.101102 (2011).
Cunningham, C. H. et al. Hyperpolarized 13C metabolic MRI of the human heart: Initial experience. Circ. Res. 119, 1177–1182, https://doi.org/10.1161/circresaha.116.309769 (2016).
Nelson, S. J. et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate. Sci. Trans. Med. 5, 198ra108–198ra108, https://doi.org/10.1126/scitranslmed.3006070 (2013).
Park, I. et al. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn. Reson. Med. https://doi.org/10.1002/mrm.27077 (2018).
Kurhanewicz, J. et al. Hyperpolarized 13C MRI: Path to clinical translation in oncology. Neoplasia 21, 1–16, https://doi.org/10.1016/j.neo.2018.09.006 (2018).
Miloushev, V. Z. et al. Metabolic imaging of the human brain with hyperpolarized 13C pyruvate demonstrates 13C lactate production in brain tumor patients. Cancer Res. 78, 3755–3760, https://doi.org/10.1158/0008-5472.can-18-0221 (2018).
Grist, J. T. et al. Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging. Neuroimage 189, 171–179, https://doi.org/10.1016/j.neuroimage.2019.01.027 (2019).
Miclet, E. et al. Toward quantitative measurements of enzyme kinetics by dissolution dynamic nuclear polarization. J. Phys. Chem. Lett. 5, 3290–3295, https://doi.org/10.1021/jz501411d (2014).
Allouche-Arnon, H. et al. Quantification of rate constants for successive enzymatic reactions with DNP hyperpolarized MR. NMR Biomed. 27, 656–662, https://doi.org/10.1002/nbm.3102 (2014).
Daniels, C. J. et al. A comparison of quantitative methods for clinical imaging with hyperpolarized 13C-pyruvate. NMR Biomed. 29, 387–399, https://doi.org/10.1002/nbm.3468 (2016).
Barb, A. W., Hekmatyar, S. K., Glushka, J. N. & Prestegard, J. H. Probing alanine transaminase catalysis with hyperpolarized 13CD3-pyruvate. J. Magn. Reson. 228, 59–65, https://doi.org/10.1016/j.jmr.2012.12.013 (2013).
Wibowo, A., Park, J. M., Liu, S.-C., Khosla, C. & Spielman, D. M. Real-time in vivo detection of H2O2 using hyperpolarized 13C-thiourea. ACS Chem. Biol. 12, 1737–1742, https://doi.org/10.1021/acschembio.7b00130 (2017).
Lerche, M. H. et al. Study of molecular interactions with 13C DNP-NMR. J. Magn. Reson. 203, 52–56, https://doi.org/10.1016/j.jmr.2009.11.020 (2010).
Ragavan, M., Iconaru, L. I., Park, C. G., Kriwacki, R. W. & Hilty, C. Real-time analysis of folding upon binding of a disordered protein by using dissolution DNP NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 56, 7070–7073, https://doi.org/10.1002/anie.201700464 (2017).
Koelsch, B. L. et al. Diffusion MR of hyperpolarized 13C molecules in solution. Analyst 138, 1011–1014, https://doi.org/10.1039/c2an36715g (2013).
Harris T., D. H. & Frydman, L. Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures. NMR Biomed. 26, 1831–1843, https://doi.org/10.1002/nbm.3024 (2013).
Allouche-Arnon, H. et al. In vivo magnetic resonance imaging of glucose - initial experience. Contrast Media Mol. Imaging 8, 72–82, https://doi.org/10.1002/cmmi.1497 (2013).
Rodrigues, T. B. et al. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose. Nat. Med. 20, https://doi.org/10.1038/nm.3416 (2014).
Mishkovsky, M. et al. Measuring glucose cerebral metabolism in the healthy mouse using hyperpolarized 13C magnetic resonance. Sci. Rep. 7, 11719, https://doi.org/10.1038/s41598-017-12086-z (2017).
Jupin, M. et al. Application of the steady-state variable nutation angle method for faster determinations of long T1s-an approach useful for the design of hyperpolarized MR molecular probes. Magn. Reson. Insights 8, 41–47, https://doi.org/10.4137/mri.s29358 (2015).
Griffin, L. D. et al. Mammalian hexokinase 1: evolutionary conservation and structure to function analysis. Genomics 11, 1014–1024 (1991).
Arora, K. K., Fanciulli, M. & Pedersen, P. L. Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase. J. Biol. Chem. 265, 6481–6488 (1990).
Miller, S., Ross-Inta, C. & Giulivi, C. Kinetic and proteomic analyses of S-nitrosoglutathione-treated hexokinase A: consequences for cancer energy metabolism. Amino Acids 32, 593–602, https://doi.org/10.1007/s00726-006-0424-9 (2007).
Goward, C. R., Hartwell, R., Atkinson, T. & Scawen, M. D. The purification and characterization of glucokinase from the thermophile Bacillus stearothermophilus. Biochem. J. 237, 415–420 (1986).
Hengartner, H. & Zuber, H. Isolation and characterization of a thermophilic glucokinase from Bacillus stearothermophilus. FEBS Lett. 37, 212–216, https://doi.org/10.1016/0014-5793(73)80461-2 (1973).
Maple, S. R. & Allerhand, A. Detailed tautomeric equilibrium of aqueous D-glucose. Observation of six tautomers by ultra high resolution carbon-13 NMR. J. Am. Chem. Soc. 109, 3168–3169, https://doi.org/10.1021/ja00244a063 (1987).
Zhu, Y., Zajicek, J. & Serianni, A. S. Acyclic forms of [1-13C]aldohexoses in aqueous solution: quantitation by 13C NMR and deuterium isotope effects on tautomeric equilibria. J. Org. Chem. 66, 6244–6251 (2001).
Bailey, J. M., Fishman, P. H. & Pentchev, P. G. Anomalous mutarotation of glucose 6-phosphate. An example of intramolecular catalysis. Biochemistry 9, 1189–1194 (1970).
Schray, K. J. & Benkovic, S. J. Anomerization rates and enzyme specificity for biologically important sugars and sugar phosphates. Acc. Chem. Res. 11, 136–141, https://doi.org/10.1021/ar50124a002 (1978).
Okuda, J., Miwa, I. & Inagaki, K. D-glucose anomeric preference of hexokinases from animals and yeast. Enzyme 31, 176–180 (1984).
Mizuma, T., Nagamine, Y., Dobashi, A. & Awazu, S. Factors that cause the beta-anomeric preference of Na+/glucose cotransporter for intestinal transport of monosaccharide conjugates. Biochim. Biophys. Acta. 1381, 340–346, https://doi.org/10.1016/s0304-4165(98)00061-0 (1998).
Fishman, P. H., Bailey, J. M. & Mutarotases, X. Anomer specific glucose transport in ascites tumor cells. Am. J. Physiol. 226, 1007–1014, https://doi.org/10.1152/ajplegacy.1974.226.4.1007 (1974).
Faust, R. G. Monosaccharide penetration into human red blood cells by an altered diffusion mechanism. J. Cell. Comp. Physiol. 56, 103–121 (1960).
Kuchel, P. W., Chapman, B. E. & Potts, J. R. Glucose transport in human erythrocytes measured using 13C NMR spin transfer. FEBS Lett. 219, 5–10, https://doi.org/10.1016/0014-5793(87)81180-8 (1987).
Carruthers, A. & Melchior, D. L. Transport of alpha- and beta-D-glucose by the intact human red cell. Biochemistry 24, 4244–4250, https://doi.org/10.1021/bi00336a065 (1985).
Miwa, I., Okuda, J., Niki, H. & Niki, A. Uptake of radioactive D-glucose anomers by pancreatic islets. J. Biochem. 78, 1109–1111, https://doi.org/10.1093/oxfordjournals.jbchem.a130990 (1975).
Fichaux, F. et al. Altered anomeric specificity of glucose-induced insulin release in rabbits with duct-ligated pancreas. Int. J. Pancreatol. 8, 151–167 (1991).
Leclercq-Meyer, V., Marchand, J. & Malaisse, W. J. Attenuated anomeric difference of glucose-induced insulin release in the perfused pancreas of diazoxide-treated rats. Horm. Metab. Res. 23, 257–261, https://doi.org/10.1055/s-2007-1003668 (1991).
Malaisse, W. J., Giroix, M. H., Dufrane, S. P., Malaisse-Lagae, F. & Sener, A. Environmental modulation of the anomeric specificity of glucose metabolism in normal and tumoral cells. Biochim. Biophys. Acta 847, 48–52, https://doi.org/10.1016/0167-4889(85)90151-x (1985).
Yu, S. Review of 18F-FDG synthesis and quality control. Biomed. Imaging Interv. J. 2, e57 (2006).
Huang, M. T. & Veech, R. L. Metabolic fluxes between [14C]2-deoxy-D-glucose and [14C]2-deoxy-D-glucose-6-phosphate in brain in vivo. J. Neurochem. 44, 567–573 (1985).
Okazumi, S. et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J. Nucl. Med. 33, 333–339 (1992).
Ho, C. L., Yu, S. C. & Yeung, D. W. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J. Nucl. Med. 44, 213–221 (2003).
Kotyk, J. J., Rust, R. S., Ackerman, J. J. & Deuel, R. K. Simultaneous in vivo monitoring of cerebral deoxyglucose and deoxyglucose-6-phosphate by 13C[1H] nuclear magnetic resonances spectroscopy. J Neurochem 53, 1620–1628, https://doi.org/10.1111/j.1471-4159.1989.tb08560.x (1989).
Schray, K. J. & Howell, E. E. Anomerization of glucose-6-phosphate - pH-dependence and solvent isotope effects. Arch. Biochem. Biophys. 189, 102–105, https://doi.org/10.1016/0003-9861(78)90120-0 (1978).
Massiot, D. et al. Modelling one‐ and two‐dimensional solid‐state NMR spectra. Magn. Reson. Chem. 40, 70–76, https://doi.org/10.1002/mrc.984 (2002).
Walker, T. E., London, R. E., Whaley, T. W., Barker, R. & Matwiyoff, N. A. Carbon-13 nuclear magnetic resonance spectroscopy of [1-13C] enriched monosaccharides. Signal assignments and orientational dependence of geminal and vicinal carbon-carbon and carbon-hydrogen spin-spin coupling constants. J. Am. Chem. Soc. 98, 5807–5813, https://doi.org/10.1021/ja00435a011 (1976).
Kouřil, K., Kouřilová, H., Levitt, M. H. & Meier, B. Dissolution-dynamic nuclear polarization with rapid transfer of a polarized solid. arXiv preprint arXiv:1807.00223 (2018).
Tropp, J. Multiplet asymmetry and multi-spin order in liquid-state NMR spectra of hyperpolarized compounds. Proc. Intl. Soc. Magn. Reson. Med. 18, 1026 (2010).
Acknowledgements
The authors thank Dr. Ayelet Gamliel for assistance with preparation of formulation for hyperpolarization and David Shaul for assistance in NMR spectral acquisitions. This project has received funding from the European Research Council (ERC) under grant agreement No. 338040, the European Union’s Horizon 2020 research and innovation program under grant agreement No. 667192, and from the Israel Innovation Authority, KAMIN Incentive program, grant agreement No. 63361.
Author information
Authors and Affiliations
Contributions
G.S. has performed the studies and analyzed the data. T.H. designed the data analysis strategy. S.U. assisted with N.M.R. acquisitions. A.N.-S. assisted with the experimental setup. J.S. and J.M.G. supported the study with infrastructure resources. R.K.-B. supervised the entire study experimentation and data analysis and recruited funding. G.S. and R.K.-B. wrote the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sapir, G., Harris, T., Uppala, S. et al. [13C6,D8]2-deoxyglucose phosphorylation by hexokinase shows selectivity for the β-anomer. Sci Rep 9, 19683 (2019). https://doi.org/10.1038/s41598-019-56063-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-56063-0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.